Shaw Timothy 4

What Happened

• Timothy Shaw, Chief Operating Officer of Marimed, had 21,667 restricted stock units (RSUs) convert to common stock on March 7, 2026 (reported 3/9/2026). The conversion is reported as a derivative exercise/conversion (code M) at $0.00 per share.
• To cover tax withholding, 7,508 shares were withheld by the issuer at $0.08 per share, a total withholding value of $631 (code F). After withholding, Shaw received a net 14,159 shares. This was a compensation vesting event (not an open-market purchase or a voluntary sale).

Key Details

• Transaction date: March 7, 2026; Filing date: March 9, 2026 (timely filing).
• Converted: 21,667 RSUs → 21,667 common shares (conversion reported at $0.00).
• Withheld for taxes: 7,508 shares @ $0.08 = $631 (shares surrendered to issuer for tax withholding).
• Net shares delivered to Shaw: 14,159.
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1—RSUs convert one-for-one to common stock; F2—shares withheld satisfy tax withholding; F4—these RSUs were granted 3/7/2023 and this grant is fully settled; F3—some shares are held in an irrevocable trust (spouse is trustee for Reporting Person’s children) and Shaw disclaims beneficial ownership of those trust-held shares.

Context

• This is a routine RSU vesting and company tax-withholding event (similar to a cashless exercise for tax purposes). It does not indicate a purchase or an open-market sale by the insider.
• Such compensation-related conversions are standard and reflect vesting of prior awards rather than a directional trade signal.